Ciprofloxacin resistance in Salmonella enterica serotype Typhi/Paratyphi and antimicrobial agent quality and bioavailability

References

1. Ofoeule S. I., Udeogaranya P. O., Okonata J. M. 2001; Prediction of in vivo bioavailability of six brands of ciprofloxacin film coated tablets using the concept of dissolution efficiency (DE). Boll Chim Farm 140:187–191
   [Google Scholar]
2. Renuka K., Sood S., Das B. K., Kapil A. 2005; High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54:999–1000 [CrossRef]
   [Google Scholar]
3. Taylor R. B., Shakoor O., Behrens R. H., Everard M., Low A. S., Wangboonskul J., Reid R. G., Kolawole J. A. 2001; Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357:1932–1936
   [Google Scholar]